SMAD4 and neoplasm: Mutations in SMAD2 and SMAD4 genes have been observed in CRCs [33]; additionally, SMAD4 copy number loss was detected in CRC patients and was associated with tumor progression [34,35], while SMAD7 was shown to be deleted or amplified in CRC [36].